Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

Chiara C. Bortolasci(Universidade Estadual de Londrina), Ken Walder(Deakin University), Barend J. Engelbrecht(North-West University), Tamsyn M. Crowley(Deakin University), Briana Spolding(Deakin University), De Wet Wolmarans(North-West University), Brad Watmuff(Deakin University), Brian H. Harvey(South African Medical Research Council), Trang T. T. Truong(Deakin University), Srisaiyini Kidnapillai(Deakin University), Katherine Drummond(The University of Melbourne), Courtney Swinton(Deakin University), Olivia Dean(Antwerp University Hospital), Terence Y. Pang(The University of Melbourne), Marion Leboyer(Université Paris-Est Créteil), Sean L. McGee(Deakin University), Christina J. Perry(Florey Institute of Neuroscience and Mental Health), Stephanie Cowdery(Deakin University), Stephan F. Steyn(North-West University), Bruna Panizzutti(Deakin University), Katerina Vlahos(Murdoch Children's Research Institute), Kiymet Bozaoglu(Murdoch Children's Research Institute), Michael Berk(The Royal Melbourne Hospital), Timothy Connor(Deakin University), Mark F. Richardson(Deakin University), Jee Hyun Kim(Deakin University), Laura Gray(Deakin University), Zoe Liu(Google (United States)), Andrew Sanigorski(Deakin University), Stéphane Jamain(Inserm)
Bipolar Disorders
March 9, 2023
Cited by 18


Related Papers